{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:45:16Z","timestamp":1790286316005,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jad.2009.08.011","type":"journal-article","created":{"date-parts":[[2009,9,7]],"date-time":"2009-09-07T04:36:02Z","timestamp":1252298162000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Rethinking depression and the actions of antidepressants: Uncovering the links between the neural and behavioral elements"],"prefix":"10.1016","volume":"120","author":[{"given":"Martin M.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2009.08.011_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jad.2004.12.004","article-title":"Agitated \u201cunipolar\u201d depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy","volume":"85","author":"Akiskal","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.08.011_bib2","series-title":"Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence","first-page":"S1","volume":"10","year":"2007"},{"key":"10.1016\/j.jad.2009.08.011_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S1461145704004870","article-title":"Evidence-based pharmacotherapy of Generalized Anxiety Disorder","volume":"8","author":"Baldwin","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jad.2004.07.006","article-title":"Irritable-hostile depression: further validation as a bipolar depressive mixed state","volume":"84","author":"Benazzi","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"Suppl.15","key":"10.1016\/j.jad.2009.08.011_bib5","first-page":"12","article-title":"Pharmacology of rapid-onset antidepressant treatment strategies","volume":"62","author":"Blier","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/clpt.1985.46","article-title":"Effects of amitritrypline and imipramine on brain and neurotransmitter metabolites in cerebrospinal fluid","volume":"37","author":"Bowden","year":"1985","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2009.08.011_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archpsyc.1965.01730060001001","article-title":"Norepinephrine in depressive patients","volume":"13","author":"Bunney","year":"1965","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-0028-1094471","article-title":"The contribution of drug research to investigating the nature of endogenous depression","volume":"9","author":"Carlsson","year":"1976","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archpsyc.1985.01790340082012","article-title":"Somatic symptoms in primary affective disorder: presence and relationship to the classification of depression","volume":"42","author":"Casper","year":"1965","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2009.08.011_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1037\/0021-843X.100.3.316","article-title":"Tripartite model of anxiety and depression: psychometrics and taxonomic implications","volume":"100","author":"Clark","year":"1991","journal-title":"J. Abnorm. Psychology"},{"key":"10.1016\/j.jad.2009.08.011_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0033291700043385","article-title":"Early improvement as a predictor of response to amitriptyline and nortriptiptyline: a comparison of two patient samples","volume":"12","author":"Coryell","year":"1982","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2009.08.011_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.1988.01800320015002","article-title":"Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls","volume":"45","author":"Davis","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00004850-199206004-00014","article-title":"The anti-anxiety and anti-agitation effects of paroxetine in depressed patients","volume":"6","author":"Dunbar","year":"1992","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib14","first-page":"1","article-title":"Anger attacks in depression","volume":"6","author":"Fava","year":"2005","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2009.08.011_bib15","series-title":"The Phenomena of Depression","author":"Grinker","year":"1961"},{"key":"10.1016\/j.jad.2009.08.011_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-7258(95)00004-Z","article-title":"5-Hydroxytryptamine pathways in anxiety and its treatment","volume":"66","author":"Handley","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2009.08.011_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S146114570000198X","article-title":"Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine","volume":"3","author":"Javors","year":"2000","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1986.01800010081010","article-title":"Imipramine and chlordiazepoxide in depression and anxiety disorders, I: efficacy in anxious outpatients","volume":"43","author":"Kahn","year":"1979","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2466\/pr0.1984.55.2.619","article-title":"A multi-vantaged approach to measurement of behavioral and affect states for clinical and psychobiological research","volume":"55","author":"Katz","year":"1984","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.jad.2009.08.011_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0033291700024831","article-title":"The timing, specificity and clinical prediction of tricyclic drug effects in depression","volume":"17","author":"Katz","year":"1987","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2009.08.011_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S0033291700022236","article-title":"Identifying the specific clinical actions of amitriptyline: interrelationships of behavior, affect, and plasma levels in depression","volume":"21","author":"Katz","year":"1991","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2009.08.011_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/npp.1994.16","article-title":"Psychopharmacology and the etiology of psychopathological states: are we looking in the right way?","volume":"10","author":"Katz","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2009.08.011_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/npp.1994.38","article-title":"Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients","volume":"11","author":"Katz","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2009.08.011_bib25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.npp.1300341","article-title":"Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression","volume":"29","author":"Katz","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2009.08.011_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S1461145704004407","article-title":"A multivantaged behavioral method for measuring onset and sequence of the clinical actions of antidepressants","volume":"7","author":"Katz","year":"2004","journal-title":"Int'l. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.jcp.0000246220.04422.de","article-title":"Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development","volume":"26","author":"Katz","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib27","series-title":"The Classification of Depressive Illnesses","author":"Kendell","year":"1968"},{"key":"10.1016\/j.jad.2009.08.011_bib28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1176\/ajp.142.11.1291","article-title":"Depressive behavior and hyperactive adrenocortical function","volume":"142","author":"Kocsis","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archpsyc.1983.01790080081011","article-title":"CSF and urinary biogenic amines and metabolites in depression and mania","volume":"40","author":"Koslow","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib30","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/0024-3205(83)90344-2","article-title":"Low cerebrospinal fluid 5-hydroxyindoleacetic acid and concentration differentiates impulsive from nonimpulsive violent behavior","volume":"33","author":"Linnoila","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.jad.2009.08.011_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1520-6394(2000)11:3<99::AID-DA3>3.0.CO;2-Z","article-title":"Therapeutic advances: paroxetine for the treatment of social anxiety disorder","volume":"11","author":"Lydiard","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2009.08.011_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1017\/S0033291700055057","article-title":"Biological component of the NIMH Clinical Research Branch Collaborative Program on the Psychobiology of Depression I. Background and theoretical considerations","volume":"10","author":"Maas","year":"1980","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2009.08.011_bib33","first-page":"1139","article-title":"Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs","volume":"141","author":"Maas","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib34","first-page":"155","article-title":"Current evidence regarding biological hypotheses of depression and accompanying pathophysiological processes: a critique and synthesis of results using clinical and basic results","volume":"7","author":"Maas","year":"1991","journal-title":"Integr. Psychiatr."},{"key":"10.1016\/j.jad.2009.08.011_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000155821.74832.f9","article-title":"A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder","volume":"25","author":"Mitte","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressant brain monoaminergic systems a dimensional approach to understanding their effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-0327(91)90102-X","article-title":"Prediction of efficacy by 1-week test therapy in depression","volume":"23","author":"Nagayama","year":"1991","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.08.011_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000195042.62724.76","article-title":"A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder","volume":"26","author":"Papakostas","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4088\/JCP.v66n0201","article-title":"Is there a delay in the antidepressant effect? J","volume":"66","author":"Posternak","year":"2005","journal-title":"Clin. Psychiatr."},{"key":"10.1016\/j.jad.2009.08.011_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archpsyc.1984.01790190056007","article-title":"Identification of true drug response to antidepressants","volume":"41","author":"Quitkin","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib43","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archpsyc.1986.01800100028005","article-title":"Cerebrospinal fluid biogenic amine metabolite relationships with behavioral measurement in unipolar and bipolar depressed, manic and healthy control subjects","volume":"43","author":"Redmond","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib44","series-title":"Diagnosis of Depression","article-title":"The classification of depressive disorders in the tenth revision of the International Classification of Disease (ICD-10)","author":"Sartorious","year":"1991"},{"key":"10.1016\/j.jad.2009.08.011_bib45","series-title":"Antidepressants, Manual of Clinical Psychopharmacology","author":"Schatzberg","year":"2003"},{"key":"10.1016\/j.jad.2009.08.011_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jad.2009.08.011_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1017\/S0033291700055069","article-title":"Biological component of the NIMH Clinical Research Branch Collaborative Program on the Psychobiology of Depression II Methodology and data analysis","volume":"10","author":"Secunda","year":"1980","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2009.08.011_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0924-977X(93)90264-M","article-title":"Time course of improvement under antidepressant treatment: a survival-analytic approach","volume":"3","author":"Stassen","year":"1993","journal-title":"European Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.08.011_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0924-9338(97)89100-6","article-title":"Delayed onset of action of antidepressant drugs? Survey of recent results","volume":"12","author":"Stassen","year":"1997","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.jad.2009.08.011_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archpsyc.1984.01790140047006","article-title":"Pretreatment DST and hypothalamic\u2013pituitary\u2013adrenocortical function in depressed patients and comparison groups. A multicenter study","volume":"41","author":"Stokes","year":"1984","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.jad.2009.08.011_bib51","series-title":"Darkness Visible: A Memoir of Madness","author":"Styron","year":"1990"},{"key":"10.1016\/j.jad.2009.08.011_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archpsyc.1987.01800160057008","article-title":"Lithium carbonate treatment of mania: cerebrospinal fluid and urinary monoamine metabolites and treatment outcome","volume":"44","author":"Swann","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4088\/JCP.v64n0410","article-title":"Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression","volume":"64","author":"Szegedi","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.08.011_bib54","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of SSRI antidepressant action: systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2009.08.011_bib55","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-asperate in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709003887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709003887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:08:18Z","timestamp":1759021698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032709003887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":56,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0165032709003887"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2009.08.011","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking depression and the actions of antidepressants: Uncovering the links between the neural and behavioral elements","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2009.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}